Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trialOrnella Verrastro, Geltrude Mingrone, Fabio Maria Vecchio et al.|The Lancet|2023Cited by 338
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosisGiulia Angelini, Geltrude Mingrone, Simona Panunzi et al.|Gut|2022Cited by 55
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetesErminia Lembo, Esmeralda Capristo, Maria Francesca Russo et al.|Diabetes & Metabolism|2022Cited by 22
Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric SurgeryGiulia Angelini, Royce P Vincent, Simona Panunzi et al.|Clinical Chemistry|2024Cited by 2
Comparing non-invasive biomarkers of non-alcoholic steatohepatitis in obesityRoyce P Vincent, Geltrude Mingrone, Simona Panunzi et al.|Obesity Abstracts|2024Cited by 0